HomeRVU • WSE
add
Ryvu Therapeutics SA
Previous close
zł 25.00
Day range
zł 23.95 - zł 25.25
Year range
zł 17.62 - zł 52.80
Market cap
561.82M PLN
Avg Volume
30.63K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
BNN Bloomberg
1 day ago
Central bank commentary weighs on risk assets, following BoC and Fed rate cuts
0.11%
Financials
Income Statement
Revenue
Net income
| (PLN) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 95.03M | 17.44% |
Operating expense | 73.34M | 6.91% |
Net income | -4.61M | 54.01% |
Net profit margin | -4.85 | 60.82% |
Earnings per share | — | — |
EBITDA | 18.31M | 105.94% |
Effective tax rate | -2.51% | — |
Balance Sheet
Total assets
Total liabilities
| (PLN) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.41M | -94.33% |
Total assets | 619.09M | 52.24% |
Total liabilities | 303.25M | 50.69% |
Total equity | 315.84M | — |
Shares outstanding | 18.36M | — |
Price to book | 1.45 | — |
Return on assets | 0.85% | — |
Return on capital | 1.08% | — |
Cash Flow
Net change in cash
| (PLN) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -4.61M | 54.01% |
Cash from operations | 66.50M | 7.46% |
Cash from investing | -42.73M | 59.66% |
Cash from financing | -23.54M | 62.00% |
Net change in cash | 212.00K | 100.19% |
Free cash flow | -36.89M | -191.40% |
About
Founded
2007
Website
Employees
328
